News

Stockhead on MSN3h
Health Check: And the EOFY biotech winner is … gasp … a pot stock
The medicinal cannabis purveyor Bioxyne was the top performing ASX biotech in 2024-25,  recording a 720% share gain.
The Manila Times5h
Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure
Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items ...